The CD95 Type I/Type II model
Abstract
CD95 (APO-1/Fas) has become the prototype of a death domain containing receptor and is the best studied member of the death receptors that activate the extrinsic apoptosis pathway. This pathway is initiated by recruitment and activation of caspase-8, an initiator caspase, in the death-inducing signaling complex (DISC) followed by direct cleavage of downstream effector caspases. In contrast, the intrinsic apoptosis pathway starts from within the cell either by direct activation of caspases or through intracellular changes such as DNA damage resulting in the release of a number of pro-apoptotic factors from the intermembrane space of mitochondria. The release of these factors results in the activation of another initiator caspase, caspase-9, and ultimately in the activation of effector caspases in a protein complex called the apoptosome. In recent years, it has become apparent that there is cross talk between the extrinsic and intrinsic pathway. In the death receptor pathway of apoptosis induction, the best characterized connection between the two pathways is the Bcl-2 family member Bid which translocates to mitochondria after cleavage by caspase-8 causing pro-apoptotic changes. Cells that die through CD95 without help from mitochondria are called Type I cells, whereas cells in which CD95-mediated death relies mostly on the intrinsic pathway are called Type II. This review focuses on recent developments in the delineation of the biochemistry and the physiological function of the two CD95 pathways.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In type I cells (e.g., thymocytes and mature lymphocytes), CASP8-dependent proteolytic maturation of executioner CASP3 and CASP7 suffices to drive RCD, which cannot be inhibited by transgene-driven overexpression of anti-apoptotic BCL2 proteins, co-deletion of Bax and Bak1, or loss of BID.
“In so-called “type I cells” (e.g., thymocytes and mature lymphocytes) the CASP8-dependent proteolytic maturation of executioner CASP3 and CASP7 suffices to drive RCD, which cannot be inhibited by the transgene-driven overexpression of anti-apoptotic BCL2 proteins, the co-deletion of Bax and Bak1, or the loss of BID [308, 309].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [308]
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,998 · see citing works
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 7,295 · see citing works
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289 · see citing works
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445 · see citing works
Molecular characterization of mitochondrial apoptosis-inducing factor
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999) · Nature · doi:10.1038/17135 · Cited by 4,060 · see citing works
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988 · see citing works
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626 · see citing works
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513 · see citing works
Two CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000 · see citing works
Self-citationVerhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372 · see citing works
Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., & Peter, M. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00245.x · Cited by 2,181 · see citing works
Self-citationAutocrine T-cell suicide mediated by APO-1/(Fas/CD95)
Dhein, J., Walczak, H., Bäumler, C., Debatin, K., & Krammer, P. (1995) · Nature · doi:10.1038/373438a0 · Cited by 1,814 · see citing works
Endonuclease G is an apoptotic DNase when released from mitochondria
Li, L. Y., Luo, X., & Wang, X. (2001) · Nature · doi:10.1038/35083620 · Cited by 1,787 · see citing works
Reduced Apoptosis and Cytochrome c–Mediated Caspase Activation in Mice Lacking Caspase 9
Kuida, K., Haydar, T. F., Kuan, C.-Y., Gu, Y., Taya, C., Karasuyama, H., Su, M. S.-S., Rakic, P., & Flavell, R. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81476-2 · Cited by 1,643 · see citing works
Lindsten, T., Ross, A. J., King, A., Zong, W.-X., Rathmell, J. C., Shiels, H. A., Ulrich, E., Waymire, K. G., Mahar, P., Frauwirth, K., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00136-2 · Cited by 1,489 · see citing works
Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death
Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Science · doi:10.1126/science.270.5233.96 · Cited by 1,480 · see citing works
Deveraux, Q. L., Roy, N., Stennicke, H. R., Arsdale, T. V., Zhou, Q., Srinivasula, S. M., Alnemri, E. S., Salvesen, G. S., & Reed, J. C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2215 · Cited by 1,390 · see citing works
Grell, M., Douni, E. K., Wajant, H., Löhden, M., Clauss, M. A., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G. A., Pfizenmaier, K., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90192-2 · Cited by 1,328 · see citing works
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,299 · see citing works
Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo
Hakem, R., Hakem, A., Duncan, G. S., Henderson, J. T., Woo, M., Soengas, M. S., Elia, A., de la Pompa, J. L., Kägi, D., Khoo, W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81477-4 · Cited by 1,284 · see citing works
FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC)
Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevchenko, A., Mann, M., Krammer, P. H., & Peter, M. E. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2794 · Cited by 1,189 · see citing works
Self-citationApaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
Yoshida, H., Kong, Y., Yoshida, R., Elia, A., Hakem, A., Hakem, R., Penninger, J. M., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81733-x · Cited by 1,138 · see citing works
TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL
Walczak, H., Degli‐Esposti, M. A., Johnson, R. S., Smolak, P. J., Waugh, J. Y., Boiani, N., Timour, M. S., Gerhart, M. J., Schooley, K. A., Smith, C. A., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5386 · Cited by 1,130 · see citing works
Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
Yin, X.-M., Wang, K., Gross, A., Zhao, Y., Zinkel, S., Klocke, B., Roth, K. A., & Korsmeyer, S. J. (1999) · Nature · doi:10.1038/23730 · Cited by 1,004 · see citing works
Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5
Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., & Ashkenazi, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80212-5 · Cited by 975 · see citing works
Schneider, P., Holler, N., Bodmer, J.-L., Hahne, M., Frei, K., Fontana, A., & Tschopp, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1205 · Cited by 804 · see citing works
Sprick, M. R., Weigand, M. A., Rieser, E., Rauch, C. T., Juo, P., Blenis, J., Krammer, P. H., & Walczak, H. (2000) · Immunity · doi:10.1016/s1074-7613(00)80211-3 · Cited by 799 · see citing works
Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis.
Strasser, A., Harris, A. W., Huang, D. C., Krammer, P. H., & Cory, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00304.x · Cited by 784 · see citing works
Downregulation of Fas ligand by shedding
Tanaka, M., Itai, T., Adachi, M., & Nagata, S. (1998) · Nature Medicine · doi:10.1038/nm0198-031 · Cited by 666 · see citing works
Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., et al. (1996) · Nature Medicine · doi:10.1038/nm0396-317 · Cited by 660 · see citing works
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
Bodmer, J.-L., Holler, N., Reynard, S., Vinciguerra, P., Schneider, P., Juo, P., Blenis, J., & Tschopp, J. (2000) · Nature Cell Biology · doi:10.1038/35008667 · Cited by 644 · see citing works
Expression of the functional soluble form of human fas ligand in activated lymphocytes.
Tanaka, M., Suda, T., Takahashi, T., & Nagata, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07096.x · Cited by 639 · see citing works
Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells
Scaffidi, C., Schmitz, I., Zha, J., Korsmeyer, S. J., Krammer, P. H., & Peter, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22532 · Cited by 580 · see citing works
Self-citationDual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways
Vercammen, D., Brouckaert, G., Denecker, G., Van de Craen, M., Declercq, W., Fiers, W., & Vandenabeele, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.919 · Cited by 556 · see citing works
LeBlanc, H. N., Lawrence, D. A., Varfolomeev, E. E., Tótpál, K., Morlan, J., Schow, P. W., Fong, S. E., SCHWALL, R. H., Sinicropi, D. V., & Ashkenazi, A. (2002) · Nature Medicine · doi:10.1038/nm0302-274 · Cited by 500 · see citing works
TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLOPreprint
Deng, Y., Lin, Y., & Wu, X. (2002) · Genes & Development · doi:10.1101/gad.949602 · Cited by 456 · see citing works
Ruvolo, P. P., Deng, X., Carr, B. K., & May, W. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25436 · Cited by 452 · see citing works
Powell, W. C., Fingleton, B., Wilson, C. L., Boothby, M. R., & Matrisian, L. M. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80113-x · Cited by 424 · see citing works
Suliman, A., Lam, A., Datta, R., & Srivastava, R. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204282 · Cited by 417 · see citing works
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression
Fulda, S., Meyer, É., & Debatin, K. (2002) · Oncogene · doi:10.1038/sj.onc.1205258 · Cited by 394 · see citing works
Molecular Ordering of the Initial Signaling Events of CD95
Algeciras-Schimnich, A., Shen, L., Barnhart, B. C., Murmann, A. E., Burkhardt, J. K., & Peter, M. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.207-220.2002 · Cited by 393 · see citing works
Self-citationBcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice
Penard‐Lacronique, V., Mignon, A., Fabrè, M., Viollet, B., Rouquet, N., Molina, T. J., Porteu, A., Henrion‐Caude, A., Bouscary, D., Varlet, P., et al. (1996) · Nature Medicine · doi:10.1038/nm0196-80 · Cited by 367 · see citing works
Srinivasula, S. M., Datta, P., Fan, X., Fernandes‐Alnemri, T., Huang, Z., & Alnemri, E. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000533200 · Cited by 354 · see citing works
Huang, D. C. S., Hahne, M., Schroeter, M., Frei, K., Fontana, A., Villunger, A., Newton, K., Tschopp, J. F., & Strasser, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14871 · Cited by 300 · see citing works
p90RSK Blocks Bad-mediated Cell Death via a Protein Kinase C-dependent Pathway
Tan, Y., Ruan, H., Demeter, M. R., & Comb, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34859 · Cited by 241 · see citing works
Sun, X.-M., Bratton, S. B., Butterworth, M., MacFarlane, M., & Cohen, G. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109893200 · Cited by 237 · see citing works
Defining Characteristics of Types I and II Apoptotic Cells in Response to TRAIL
Özören, N., & El‐Deiry, W. S. (2002) · Neoplasia · doi:10.1038/sj.neo.7900270 · Cited by 236 · see citing works
Parlato, S., Giammarioli, A. M., Logozzi, M., Lozupone, F., Matarrese, P., Luciani, F., Falchi, M., Malorni, W., & Fais, S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5123 · Cited by 216 · see citing works
Zhang, X. D., Zhang, X., Gray, C. P., Nguyen, T., & Hersey, P. (2001) · PubMed · Cited by 200 · see citing works
Walczak, H., Bouchon, A., Stahl, H. F., & Krammer, P. H. (2000) · PubMed · Cited by 199 · see citing works
Rodríguez, I., Matsuura, K., Khatib, K., Reed, J. C., Nagata, S., & VASSALLI, P. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.3.1031 · Cited by 181 · see citing works
Phosphorylation by Protein Kinase CK2
Li, P., Li, J., Müller, E., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00600-7 · Cited by 172 · see citing works
Generation and Characterization of Smac/DIABLO-Deficient Mice
Okada, H., Suh, W., Jin, J., Woo, M., Du, C., Elia, A., Duncan, G. S., Wakeham, A. C., Itié, A., Lowe, S. W., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3509-3517.2002 · Cited by 172 · see citing works
Lethal effect of recombinant human Fas ligand in mice pretreated with Propionibacterium acnes
Tanaka, M., Suda, T., Yatomi, T., Nakamura, N., & Nagata, S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2303 · Cited by 160 · see citing works
Srinivasan, A. N., Li, F., Wong, A., Kodandapani, L., Smidt, R., Krebs, J., Fritz, L. C., Wu, J. C., & Tomaselli, K. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4523 · Cited by 159 · see citing works
Bratton, S. B., Lewis, J., Butterworth, M., Duckett, C. S., & Cohen, G. M. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401069 · Cited by 126 · see citing works
TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2
Munshi, A., Pappas, G., Honda, T., McDonnell, T. J., Younes, A., Li, Y., & Meyn, R. E. (2001) · Oncogene · doi:10.1038/sj.onc.1204504 · Cited by 117 · see citing works
Bcl-xL Acts Downstream of Caspase-8 Activation by the CD95 Death-inducing Signaling Complex
Medema, J. P., Scaffidi, C., Krammer, P. H., & Peter, M. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3388 · Cited by 114 · see citing works
Self-citationZhou, T., Song, L., Yang, P., et al. (1999) · Nature Medicine · doi:10.1038/4723 · Cited by 113 · see citing works
Inactivation of Caspase-8 on Mitochondria of Bcl-xL-expressing MCF7-Fas Cells
Stegh, A. H., Barnhart, B. C., Volkland, J., Algeciras-Schimnich, A., Ning, K., Reed, J. C., & Peter, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108947200 · Cited by 107 · see citing works
Self-citationFailure of Bcl‐2 to block cytochrome c redistribution during TRAIL‐induced apoptosis
Keogh, S. A., Walczak, H., Bouchier‐Hayes, L., & Martin, S. J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01375-2 · Cited by 106 · see citing works
Kulms, D., Düßmann, H., Pöppelmann, B., Ständer, S., Schwarz, A., & Schwarz, T. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401002 · Cited by 98 · see citing works
Gómez-Angelats, M., & Cidlowski, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104919200 · Cited by 94 · see citing works
Extracellular matrix interacts with soluble CD95L: Retention and enhancement of cytotoxicity
Aoki, K., Kurooka, M., Chen, J., Petryniak, J., Nabel, E. G., & Nabel, G. J. (2001) · Nature Immunology · doi:10.1038/86336 · Cited by 91 · see citing works
Varadhachary, A. S., Edidin, M. A., Hanlon, A. M., Peter, M. E., Krammer, P. H., & Salgame, P. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6564 · Cited by 88 · see citing works
Self-citationSchmitz, I., Walczak, H., Krammer, P. H., & Peter, M. E. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400569 · Cited by 84 · see citing works
Self-citationProtein Kinase C-θ Mediates a Selective T Cell Survival Signal Via Phosphorylation of BAD
Villalba, M., Bushway, P., & Altman, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5955 · Cited by 83 · see citing works
Peter, M. E., Scaffidi, C., Medema, J. P., Kischkel, F. C., & Krammer, P. H. (1999) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69184-6_3 · Cited by 82 · see citing works
Self-citationMeng, X. W., Heldebrant, M. P., & Kaufmann, S. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107218200 · Cited by 77 · see citing works
Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis
Rokhlin, O. W., Guseva, N., Taghiyev, A. F., Knudson, C. M., & Cohen, M. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204410 · Cited by 68 · see citing works
Salvesen, G. S., & Renatus, M. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00137-5 · Cited by 64 · see citing works
Werner, A. B., de Vries, E., Tait, S. W. G., Bontjer, I., & Borst, J. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204351200 · Cited by 64 · see citing works
Activation of protein kinase C attenuates early signals in Fas‐mediated apoptosis
Ruiz‐Ruiz, M. D. C., Izquierdo, M., de MURCIA, G., et al. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270622 · Cited by 55 · see citing works
Bone densitometry: Clinical considerations
Levis, S., & Altman, R. D. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199804)41:4 · Cited by 52 · see citing works
Herrant, M., Luciano, F., Loubat, A., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205689 · Cited by 45 · see citing works
Huang, D. C. S., Tschopp, J., & Strasser, A. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400683 · Cited by 37 · see citing works
Inhibition of the protein kinase C pathway promotes anti-CD95-induced apoptosis in Jurkat T cells
Drew, L. (1998) · International Immunology · doi:10.1093/intimm/10.7.877 · Cited by 31 · see citing works
Bando, M., Miyake, Y., Shiina, M., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6199 · Cited by 27 · see citing works
Schmitz, I., Walczak, H., Krammer, P. H., et al. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400707 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680 · see citing works
Self-citationReactive oxygen species, cellular redox systems, and apoptosis
Circu, M. L., & Aw, T. Y. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.022 · Cited by 3,340 · see citing works
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421 · see citing works
Self-citationCell death modalities: classification and pathophysiological implications
Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402148 · Cited by 832 · see citing works
Environmental toxicity, oxidative stress and apoptosis: Ménage à Trois
Franco, R., Sánchez-Olea, R., Reyes-Reyes, E. M., & Panayiotidis, M. I. (2009) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2008.11.012 · Cited by 541 · see citing works
Phototherapy in cancer treatment: strategies and challenges
Cai, Y., Chai, T., Nguyen, W., Liu, J., Xiao, E., Ran, X., Ran, Y., Du, D., Chen, W., & Chen, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02140-y · Cited by 453 · see citing works
Gump, J. M., Staskiewicz, L., Morgan, M. J., Bamberg, A., Riches, D. W. H., & Thorburn, A. (2014) · Nature Cell Biology · doi:10.1038/ncb2886 · Cited by 230 · see citing works
Surviving apoptosis: life–death signaling in single cells
Flusberg, D. A., & Sorger, P. K. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.03.003 · Cited by 149 · see citing works
Pradhan, S., Kim, H. K., Thrash, C. J., Cox, M. A., Mantena, S. K., Wu, J.-H., Athar, M., Katiyar, S. K., Elmets, C. A., & Timares, L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3077 · Cited by 28 · see citing works
Therapeutics Targeting the Core Apoptotic Machinery
Hamilton, C., Fox, J. P., Longley, D. B., & Higgins, C. A. (2021) · Cancers · doi:10.3390/cancers13112618 · Cited by 26 · see citing works
- Authors
- Barnhart, B. C., Alappat, E. C., & Peter, M. E.
- Affiliations
- University of Chicago (US)
- Corresponding author
- Peter, Marcus E.
- Venue
- Seminars in Immunology
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 15
- Issue
- 3
- Pages
- 185-193
- ISSN
- 1044-5323 (ISSN-L)
- OpenAlex
- W2098641105
- Cited by
- 419
- References
- 79
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 4 · 2023: 9 · 2022: 9 · 2021: 9 · 2020: 8 · 2019: 9 · 2018: 9 · 2017: 8 · 2016: 11 · 2015: 13 · 2014: 15 · 2013: 28 · 2012: 25
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (GM61712, R01GM061712)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Social Sciences › Anthropology › Death, Funerary Practices, and Mourning
- Keywords
- Fas, death receptors, extrinsic apoptotic pathway, mitochondrial apoptosis, caspase-8, caspase-9, apoptosome, death-inducing signaling complex, Bcl-2 family proteins, Bid
- MeSH terms
- Animals, Humans, Membrane Glycoproteins, Mitochondria, Signal Transduction, Models, Immunological, fas Receptor, Fas Ligand Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review